AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Rating of “Moderate Buy” by Analysts

AngioDynamics, Inc. (NASDAQ:ANGO) has been assigned a consensus rating of “Moderate Buy” from the five brokerages that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $19.3333.

A number of brokerages recently weighed in on ANGO. Zacks Research raised AngioDynamics from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 9th. Wall Street Zen cut AngioDynamics from a “buy” rating to a “hold” rating in a research report on Sunday, December 21st. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of AngioDynamics in a report on Wednesday, January 21st.

Institutional Trading of AngioDynamics

Several institutional investors have recently modified their holdings of ANGO. Divisadero Street Capital Management LP lifted its position in AngioDynamics by 253.7% in the second quarter. Divisadero Street Capital Management LP now owns 3,395,430 shares of the medical instruments supplier’s stock worth $33,683,000 after purchasing an additional 2,435,365 shares during the period. Kotler Kevin bought a new stake in shares of AngioDynamics in the 4th quarter valued at approximately $21,997,000. Weber Capital Management LLC ADV acquired a new position in shares of AngioDynamics in the 4th quarter worth approximately $17,978,000. UBS Group AG lifted its position in shares of AngioDynamics by 83.6% during the 3rd quarter. UBS Group AG now owns 1,102,488 shares of the medical instruments supplier’s stock worth $12,315,000 after buying an additional 501,881 shares during the period. Finally, Millennium Management LLC lifted its position in shares of AngioDynamics by 28.1% during the 3rd quarter. Millennium Management LLC now owns 1,793,152 shares of the medical instruments supplier’s stock worth $20,030,000 after buying an additional 393,682 shares during the period. Institutional investors and hedge funds own 89.43% of the company’s stock.

AngioDynamics Stock Down 2.8%

Shares of ANGO opened at $11.04 on Wednesday. AngioDynamics has a 12 month low of $8.27 and a 12 month high of $13.99. The company’s fifty day moving average is $11.13 and its 200-day moving average is $11.45. The firm has a market cap of $455.07 million, a price-to-earnings ratio of -16.48 and a beta of 0.48.

About AngioDynamics

AngioDynamics, Inc is a medical technology company headquartered in Latham, New York, that develops, manufactures and markets a broad range of minimally invasive medical devices. The company’s products focus on three core areas: vascular access, peripheral vascular intervention and interventional oncology. Its solutions are designed to improve procedural outcomes, reduce complications and enhance patient comfort in hospital and outpatient settings.

In the vascular access segment, AngioDynamics offers a portfolio of devices including implanted ports, peripherally inserted central catheters (PICCs), hemodialysis catheters and specialty blood management products.